Biodesix to participate in two upcoming investor conferences in september

Boulder, colo.--(business wire)---- $bdsx #patientsfirst--biodesix, inc. (nasdaq: bdsx), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced scott hutton, chief executive officer of biodesix, will participate in two upcoming investor conferences: morgan stanley 20th annual global healthcare conference date: tuesday, september 13, 2022 at 9:10 a.m. et format: fireside chat and 1x1 meetings location: sheraton hotel, new york, ny details: the fireside chat will be webcast live
BDSX Ratings Summary
BDSX Quant Ranking